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Abstract: The avarone/avarol quinone/hydroquinone couple shows considerable
antitumor activity. In this work, covalent modification of -lactoglobulin by avaro-
ne and its derivatives as well as by the synthetic steroidal quinone 2,5(10)-estra-
diene-1,4,17-trione and its derivatives were studied. The techniques for studying
chemical modification of -lactoglobulin by quinones were: UV/Vis spectrop-
hotometry, SDS PAGE and isoelectrofocusing. SDS PAGE results suggest that poly-
merization of the protein occurs. It could be seen that the protein of 18 kD gives the
bands of 20 kD, 36 kD, 40 kD, 45 kD, 64 kD and 128 kD depending on modification
agent. The shift of the pI of the protein (5.4) upon modification toward lower values
(from pI 5.0 to 5.3) indicated that lysine amino groups are the principal site of the re-
action of -lactoglobulin with the quinones.
Keywords: quinone, avarone, steroidal quinones, -lactoglobulin, covalent modifi-
cation.
INTRODUCTION
The sesquiterpene quinone/hydroquinone couple avarone/avarol, isolated from
the marine sponge Dysidea avara, and some of their derivatives exhibit a potent
antitumor activity. Their activity can be attributed to generation of oxygen radicals
leading to DNA damage,1–3 inhibition of enzymes2 and microtubule assembly,4 as
well as to alkylation of cellular nucleophiles by the quinone moiety.5,6 Avarone
was found to modify sulfhydryl groups both in glutathione and in bovine serum al-
bumin.5 In our previous publication on this subject, it was shown that avarone (Ia,
Scheme 1) and some of its alkylthio derivatives covalently modify lysine amino
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groups in the model protein -lactoglobulin (-LG),7 and that the biological activ-
ity is partly correlated to ability of the quinone to modify the protein. Namely,
those alkylthio derivatives that do not modify the protein also have the lowest
antitumor activity.6 -Lactoglobulin was selected as model protein because it has a
relatively low molecular mass and several lysine residues,
8 but only one, hindered,
cysteine residue.9 Besides that, it is readily available and can be isolated in a very
pure state. In order to confirm the generality of the reaction of -lactoglobulin with
quinones, in this work chemical modification of -lactoglobulin by avarone deriv-
atives with electron-donating substituents was studied. Such derivatives were cho-
sen because they are less susceptible to nucleophilic attack. We also compared the
protein modifying ability of compounds Ia–Id, which all have a rearranged
drimane skeleton, with those of steroidal quinone 2,5(10)-estradiene-1,4,17-trione
(IIa) and its derivatives (IIb,c).
EXPERIMENTAL
Avarol was isolated from fresh samples of D. avara, collected in the Bay of Kotor, and oxi-
dized to avarone with silver oxide.10 The steriodal quinone 2,5(10)-estradiene-1,4,17-trione was
prepared as presented earlier.11 Methoxy and methylamino derivatives of the above mentioned
sesquiterpene and steroidal quinones were synthesized as previously reported.12–14
-Lactoglobulin, 18 kD protein, was isolated from cow milk by a standard procedure.
15 The
obtained protein solution was concentrated by ultrafiltration using Amicon P10 membrane and then
lyophilized.
Modifications of -lactoglobulin were performed in 20 % EtOH containing 50 mM NaHCO3.
The concentrations of the protein and the quinones were 5 mg/ml and 2 mg/ml, respectively. By op-
timization experiments, these concentrations were found to be the most suitable ones. The final vol-
ume was 1.2 ml, and the reaction was carried out at r.t. with stirring. After 48 h, the mixture was de-
salted on a PD-10 desalting column (Amersham Biosciences) by the standard procedure16 and the
protein was eluted in the void volume.
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Scheme 1.
The chemical modification of -lactoglobulin was followed by UV/VIS spectrophotometry
(Beckman DU-50 spectrophotometer), SDS PAGE and isolectrofocusing.
SDS PAGE was performed under reducing conditions. The molecular masses of denatured
protein samples were determined on 10 % polyacrylamide gel using molecular markers of the 20.0
kD, 29.0 kD, 43.0 kD, 67.0 kD and 97.4 kD (Pharmacia, Uppsala, Sweden).17 Isoelectrofocusing
was performed on the 7.5 % polyacrylamide gel under nonreducing conditions with ampholite range
from 3–10 and a calibration pI kit (Broad pI kit 3.5–9.3, Pharmacia, Uppsala, Sweden).18
The number of sulfhydryl groups per molecule of protein was determined using Ellman’s re-
agent.19
RESULTS AND DISCUSSION
Confirmation that the reaction between the quinones and -lactoglobulin
takes place was obtained from UV/Vis spectra (Fig. 1). The modifications of the
protein were visible instantaneously by the change of colour of the reaction mix-
ture after mixing the quinone and the protein solutions. Spectral changes were visi-
ble for all tested compounds, the absorption maxima being shifted toward higher
wavelengths (Fig. 1). The wavelengths of the absorption maxima are close to those
of alkylamino derivatives of avarone, including alanino derivative, and the corre-
sponding derivatives of steroidal quinones,
12–14 so that it can be assumed that re-
action with protein amino groups occurs.
The potein modification was further investigated by SDS PAGE (Fig. 2).
Avarone Ia and its derivative 3’-methoxyavarone Ib modified the protein of the 18
kD and gave strong bands of 36 kD, 64 kD and 128 kD. Steroidal quinone IIa also
modified the protein and gave strong bands of 20 kD and 45 kD. Derivatives
4’-methylaminoavarone Ic and 3’-methylaminoavarone Id gave very sharp bands
of 40 kD and 45 kD, and derivatives 2-methoxy-2,5(10)-estradiene-1,4,17-trione
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Fig. 1. UV/Vis spectra of: a) avarone derivative Ib and the reaction mixture of Ib and -LG; b)
steroidal derivative IIb and the reaction mixture of IIb and -LG.
IIb and 2-methylamino-2,5(10)-estradiene-1,4,17-trione IIc gave a low-intensity
band of 40 kD. These results suggest that polymerization of the protein occurs in all
cases. The polymerization is most pronounced with avarone, less with its derivatives
and the unsubsituted steroidal quinone, and the least with the substituted steroidal qui-
nones. The results also indicate that various residues are the target of modification,
since derivatives Ic and Id give two bands of relatively close apparent molecular
masses, probably arising from difference in unfolding during denaturation.
The protein contains four disulphide bonds and one cysteine residue which is
not reactive because it is situated in the interior of the molecule.8 On the other
hand, the protein contains 15 reactive -amino groups of lysine residues.9 There-
fore, in this process the most likely reaction is the Michael addition of lysine NH2
groups to the quinone nucleus (Scheme 2). Radical reactions seem unlikely in view
of the fact that 3’,4’-ethylenedithioavarone, a trisubstituted derivative with which
the Michael addition does not occur, but which has a redox potential similar to
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Fig. 2. SDS PAGE electrophoregram.
Scheme 2.
those of protein-modifying monoalkylthio derivatives, does not modify the pro-
tein.7 Wtih steroidal quinones, since the polymerization occurs to some extent with
the derivatives having only one position suitable for the Michael addition, quinone
imines are likely to be involved (Scheme 3).
In order to ascertain whether the lysine -amino groups were the target of
modification, the system was studied by nonreducing isoelectrofocusing (Fig. 3),
which is often used as a method of choice for studying the nature of groups which
are modified. The shift of the pI of the protein (pI = 5.4) upon modification toward
lower values (5.0–5.3) indicated that the lysine amino groups of the protein are in-
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Scheme 3.
Fig. 3. Isoelectrofocusing gel.
deed the principal sites of the reaction with the quinones. Because of nonreducing
conditions of IEF, the polymers of high molecular weights can not completely en-
ter the gel. The result is a characteristic smir of all protein bands except for modifi-
cation with IIb and IIc, probably because these two give only one modificate of
relatively low molecular weight. The confirmation that cysteine sulfhydryl group
does not react with the quinones used was obtained by determination of mercapto
groups19 before and after modification.
CONCLUSION
In conclusion, it was shown that avarone and its derivatives modify -amino
groups of lysine residues in -lactoglobulin. The steroidal quinones, especially the
substituted ones, modify the protein to a lower extent. Therefore, it seems reason-
able to assume that the sesquiterpene moiety in avarone enables proper positioning
and non-covalent binding of the compound to the protein, which is the first, neces-
sary step for the subsequent reaction. Influence of the sesquiterpene and steroid
parts of the molecules, i.e., the overall conformation, on the reaction with proteins
might at least in part explain their specificity of action to particular types of tumor
cells,1 although additional evidence is necessary. Still, the obtained results give
new information on the mechanism of action of both avarone derivatives and
steroidal quinones, indicating covalent modification of biomolecules as a possible
mode of action.
These results might have additional significance in view of the fact that
-lactoglobulin was found to show antiviral activity upon modifications which
change the charge density of the protein.
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Hinonsko/hidrohinonski par avaron/avarol pokazuje zna~ajnu antitumorsku ak-
tivnost. U ovom radu prou~avane su kovalentne modifikacije -laktoglobulina ava-
ronom, sinteti~kim steroidnim hinonom 2,5(10)-estradien-1,4,17-trionom i wihovim
derivatima. Tehnike za pra}ewe hemijske modifikacije bile su: UV/Vis spektro-
fotometrija, SDS PAGE i izoelektrofokusirawe. Rezultati SDS PAGE ukazuju da se
de{ava polimerizacija proteina. Mo`e se videti da protein od 18 kD daje trake od 20
kD, 36 kD, 40 kD, 45 kD, 64 kD i 128 kD u zavisnosti od agensa za modifikaciju. Pome-
rawe pI vrednosti proteina (5,4) nakon modifikacije ka ni`im vrednostima (od pI 5,0
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do 5,3) pokazuje da su amino-grupe lizina glavna mesta reakcije -laktoglobulina sa
hinonima.
(Primqeno 5. jula 2004)
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